Page 29 - GTM-1-2

Global Translational Medicine IGF-1 and IGFBP-3 levels are correlated with eGFR

IGFB-3, GH and TSH levels in multiple sclerosis and their insulin-like growth factor-1 and its binding protein-3:
relationship with treatment. Neurol Res, 39: 606–611. Metabolic and genetic correlates in the community.
Arterioscler Thromb Vasc Biol, 30: 1479–1484.
https://doi.org/10.1080/01616412.2017.1321711
https://doi.org/10.1161/ATVBAHA.110.203943
13. Gatti R, De Palo E F, Antonelli G, et al., 2012, IGF-I/
IGFBP system: Metabolism outline and physical exercise. 24. Dittmann K, Wallaschofski H, Rettig R, et al., 2012,
J Endocrinol Invest, 35: 699–707. Association between serum insulin-like growth factor I or
IGF-binding protein 3 and estimated glomerular filtration
https://doi.org/10.3275/8456
rate: Results of a population-based sample. BMC Nephrol,
14. Ranke MB, 2015, Insulin-like growth factor binding- 13: 169.
protein-3 (IGFBP-3). Best Pract Res Clin Endocrinol Metab,
29: 701–711. https://doi.org/10.1186/1471-2369-13-169
25. Frystyk J, Ivarsen P, Skjaerbaek C, et al., 1999, Serum-free
https://doi.org/10.1016/j.beem.2015.06.003
insulin-like growth factor I correlates with clearance in
15. Drogan D, Schulze MB, Boeing H, et al., 2016, Insulin-like patients with chronic renal failure. Kidney Int, 56: 2076–2084.
growth factor 1 and insulin-like growth factor-binding
Protein 3 in relation to the risk of Type 2 diabetes mellitus: https://doi.org/10.1046/j.1523-1755.1999.00798.x
Results from the EPIC-potsdam study. Am J Epidemiol, 26. Bach LA, Hale LJ, 2015, Insulin-like growth factors and
183: 553–560. kidney disease. Am J Kidney Dis, 65: 327–336.
https://doi.org/10.1093/aje/kwv188 https://doi.org/10.1053/j.ajkd.2014.05.024
16. Petta S, Camma C, Cabibi D, et al., 2011, Hyperuricemia is 27. Feld SM, Hirschberg R, Artishevsky A, et al., 1995, Insulin-
associated with histological liver damage in patients with like growth factor I induces mesangial proliferation and
non-alcoholic fatty liver disease. Aliment Pharmacol Ther, increases mRNA and secretion of collagen. Kidney Int,
34: 757–766. 48: 45–51.
https://doi.org/10.1111/j.1365-2036.2011.04788.x https://doi.org/10.1038/ki.1995.265
17. Giordano M, DeFronzo RA, 1995, Acute effect of human 28. Vasylyeva TL, Chen X, Ferry RJ Jr, 2005, Insulin-like
recombinant insulin-like growth factor I on renal function growth factor binding protein-3 mediates cytokine-induced
in humans. Nephron, 71: 10–15. mesangial cell apoptosis. Growth Horm IGF Res, 15: 207–214.
https://doi.org/10.1159/000188667 https://doi.org/10.1016/j.ghir.2005.02.008
18. Hammerman MR, Miller SB, 1993, The growth hormone 29. Guler HP, Eckardt KU, Zapf J, et al., 1989, Insulin-like growth
insulin-like growth factor axis in kidney revisited. Am J factor I increase glomerular filtration rate and renal plasma
Physiol, 265: F1–F14. flow in man. Acta Endocrinol (Copenh), 121: 101–106.
https://doi.org/10.1152/ajprenal.1993.265.1.F1 https://doi.org/10.1530/acta.0.1210101
19. Jalalonmuhali M, Lim SK, Shah MN, et al., 2017, MDRD vs. 30. Hirschberg R, Kopple JD, 1989, Evidence that insulin-like
CKD-EPI in comparison to (51)Chromium EDTA: A cross growth factor I increases renal plasma flow and glomerular
sectional study of Malaysian CKD cohort. BMC Nephrol, filtration rate in fasted rats. J Clin Invest, 83: 326–330.
18: 363.
https://doi.org/10.1172/JCI113878
https://doi.org/10.1186/s12882-017-0776-2
31. Moller J, 2003, Effects of growth hormone on fluid
20. Porrini E, Ruggenenti P, Luis-Lima S, et al., 2019, Estimated homeostasis. Clinical and experimental aspects. Growth
GFR: Time for a critical appraisal. Nat Rev Nephrol, 15: 177–19. Horm IGF Res, 13: 55–74.
https://doi.org/10.1038/s41581-018-0080-9 https://doi.org/10.1016/s1096-6374(03)00011-x
21. NeamTu M C, Avramescu ET, Marcu IR, et al., 2017, 32. Kamenicky P, Mazziotti G, Lombes M, et al., 2014, Growth
The correlation between insulin-like growth factor with hormone, insulin-like growth factor-1, and the kidney:
glycemic control, glomerular filtration rate, blood pressure, Pathophysiological and clinical implications. Endocr Rev,
hematological changes or body mass index in patients with 35: 234–281.
Type 2 diabetes mellitus. Rom J Morphol Embryol, 58: 857–861.
https://doi.org/10.1210/er.2013-1071
22. Perticone F, Maio R, Sciacqua A, et al., 2009, Insulin- 33. Amit T, Youdim MB, Hochberg Z, 2000, Clinical review 112:
like growth factor-1 and glomerular filtration rate in Does serum growth hormone (GH) binding protein reflect
hypertensive patients. J Hypertens, 27: 613–617.
human GH receptor function? J Clin Endocrinol Metab,
https://doi.org/10.1097/hjh.0b013e32831fda24 85: 927–932.
23. Lam CS, Chen MH, Lacey SM, et al., 2010, Circulating https://doi.org/10.1210/jcem.85.3.6461

Volume 1 Issue 2 (2022) 9 https://doi.org/10.36922/gtm.v1i2.62